lexicon pharmaceuticals inc
(LXRX:Consolidated Issue Listed on NASDAQ Global Select )
Samuel L. Barker Ph.D.
Independent Director, Chairman of Audit Committee and Member of Compensation Committee, Lexicon Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 53 board members in 7 different organizations across 7 different industries.|
See Board Relationships
Dr. Samuel L. Barker, also known as Sam, Ph.D. was Operating Partner at Behrman Capital. Dr. Barker served at Bristol-Myers Squibb for over 35 years in research and development, manufacturing, business development, sales and marketing, and general management. After the merger of Bristol-Myers and Squibb in 1989, he assumed the position of Vice President of Asia-Pacific for the Pharmaceutical Group. Since 1991, he served as the President of Intercontinental at Bristol-Myers ...
8800 Technology Forest PlacePhone: 281-863-3000
The Woodlands, Texas 77381
Board Members Memberships*
Member of Board of Trustees
Independent Director, Chairman of Audit Committee and Member of Compensation Committee
Former Director, Member of Corporate Governance & Nominating Committee and Member of Compensation Committee
Independent Director and Chairman of Compensation Committee
Director, Member of Audit Committee and Member of Compensation & Organizational Development Committee
Henderson State University
University of Arkansas - Fayetteville
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Omar S. Ishrak||Chairman and Chief Executive Officer|
|Alex Gorsky||Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee|
Johnson & Johnson
|Miles D. White||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|Timothy M. Ring||Chairman, Chief Executive Officer and Chairman of Executive Committee|
CR Bard Inc.
|Michael F. Mahoney||Chief Executive Officer, President and Director|
Boston Scientific Corporation
|$921.3K||Compensation as of Fiscal Year 2014.|